期刊文献+

1例丙戊酸钠所致高血氨脑病的案例分析 被引量:3

A Case Report of Valproate-induced Hyperammonemic Encephalopathy
原文传递
导出
摘要 目的探讨丙戊酸钠引起高血氨脑病的机制、危险因素以及防治措施,为临床用药提供建议。方法临床药师参与并总结1例丙戊酸钠所致高血氨脑病患者的诊治。结果丙戊酸钠在与苯巴比妥、托吡酯等药物联用时可能会增加高血氨脑病的风险。结论临床上需要避免苯巴比妥等药物和丙戊酸钠的联用,对于有意识状态改变使用丙戊酸钠的患者及时监测血氨。 OBJECTIVE To investigate the mechanism, risk factors and management of valproate-induced hyperammonemic encephalopathy(VHE), provide suggestions for clinical medication. METHODS Clinical pharmacists had involved the treatment of a case of VHE. RESULTS While valproate was combined with some drugs, such as phenobarbital or topiramate, the risk of high blood ammonia encephalopathy may be enhanced. CONCLUSION It is necessary to avoid the usage of valproate combined with phenobarbital clinically, meanwhile to timely monitor ammonia of the patients who are taking valproate due to the decreased consciousness.
出处 《中国现代应用药学》 CAS CSCD 2016年第9期1202-1204,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 丙戊酸钠 高血氨脑病 危险因素 valproate valproate-induced hyperammonemic encephalopathy risk factors
  • 相关文献

参考文献9

  • 1AGARWAL R, SHARMA S, CHHILLAR N, et al. Hyperammonemia and hepatic status during valproate therapy [J]. Indian J Clin Biochem, 2009, 24(4): 366-369.
  • 2RATH A, NARYANAN T J, CHOWDHARY G V, et al. Valproate-induced hyperammonemic encephalopathy with normal liver function/-J]. Neuro India. 2005, 53(2): 226-228,.
  • 3孙振晓,于相芬.丙戊酸钠引起高血氨性脑病1例[J].药物流行病学杂志,2013,22(5):278-279. 被引量:3
  • 4LEWIS C, DESHPANDE A, TESAR G E, et al. Valproate-induced hyperammonemic encephalopathy: a brief review [J]. Curr Med Res Opin, 2012, 28(6): 1039-1042.
  • 5CHOPRA A, KOLLA B P, MANSUKHANI M P, et al. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management [J]. Gen Hosp Psychiatry, 2012, 34(3): 290 -298.
  • 6VIVEKANANDAN S, NAYAK S D. Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update [J]. Ann Indian Acad Neurol, 2010, 13(2): 145-147.
  • 7RODRIGUES-SILVA N, VEN,~NCIO ~., BOU(~A J. Risperidone, a risk factor for valproate-induced encephalopathy? [J]. Gen Hosp Psychiatry, 2013, 35(4): 452. e5-6. Doi: 10.1016/j.genhosppsych.2012.11.009.
  • 8DEUTSCH S I, BURKET J A, ROSSE R B. Valproate-induced hyperammonemic encephalopatby and normal liver functions: possible synergism with topiramate [J]. Clin Neuropharmacol, 2009, 32(6): 350-352.
  • 9ZHENG Z Q, WANG X J, YANG X L, et al. Anaphylactoid purpura induced by cefoxitin sodium: a case report [J].中国现代应用药学,2015,32(1):112-113.

二级参考文献8

  • 1喻东山,葛茂宏.精神科合理用药手册[M].第2版.南京:江苏科学技术出版社,201l:22,24.
  • 2Coulter DL, Alien RJ. Secondary hyperammonemia:a possible mechanism for valproate encephalopathy [ J ]. Lancet, 1980,1 (8181) :1310-1311.
  • 3Wadzinski J, Franks R, Roane D,-et al. Valproate-associated hyperammonemic encephalopathy [ J ]. J Am Board Fam Med,2007, 20(5) : 499-502.
  • 4Mallet L, Babin S, Morais J. Valproic acid-induced hyperam- monemia and thrombocutopenia in an elderly woman [ J ]. Ann Pharmacother, 2004,38 (10) : 1643-1647.
  • 5Hawkes ND, Thomas GA, Jurewicz A, et al. Nonhepati c hy- perammonaemia: an important, potentially reversible cause of encephalopathy[ J]. Postgrad Med J,2001,77 (913) :717- 722.
  • 6Yagi M, Nakamura T, Okizuka Y, et al. Effect of CPS14217C > A genotype on valproic-acid-induced hyperammonemia [J~. Pediatr Int,2010, 52(12) : 744- 748.
  • 7唐永亮,杨咏波,黄玉杰,那世杰,王斌.丙戊酸钠脑病一例[J].中华全科医师杂志,2011,10(4):255-255. 被引量:2
  • 8孙振晓,于相芬.丙戊酸钠导致高氨血症及脑病的研究进展[J].中华临床医师杂志(电子版),2012,6(8):151-152. 被引量:16

共引文献2

同被引文献38

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部